Non-Small Cell Lung Cancer
New Research
Seiten
2013
Nova Science Publishers Inc (Verlag)
978-1-62417-804-7 (ISBN)
Nova Science Publishers Inc (Verlag)
978-1-62417-804-7 (ISBN)
In this book, the authors present current research in the study of non-small cell lung cancer. Topics discussed include the preclinical and clinical advances of epigenetics in lung cancer; therapeutic antibodies and non-coding RNAs (ncRNAs) in non-small cell lung cancer; molecular profiling in lung cancer specimens leads to targeted therapeutic options in patients with non-small cell lung carcinoma; the role of radiation dose escalation in the treatment of stage III locally advanced inoperable non-small cell lung cancer; and mechanisms of resistance to EGFR inhibitors.
Preface; Therapeutic Antibodies in Non-Small Cell Lung Cancer: An Overview & Future Directions; Non-Coding RNAs (ncRNAs) in Non-small Cell Lung Cancer (NSCLC); Epigenetics in Lung Cancer: Preclinical & Clinical Advances; Molecular Profiling in Lung Cancer Specimens Leads to Targeted Therapeutic Options in Patients with Non-Small Cell Lung Carcinoma (NSCLC); The Role of Radiation Dose Escalation in the Treatment of Stage III Locally Advanced Inoperable Non-Small Cell Lung Cancer: Where Are We Now?; Mechanisms of Resistance to EGFR Inhibitors; Index.
Erscheint lt. Verlag | 1.7.2013 |
---|---|
Verlagsort | New York |
Sprache | englisch |
Maße | 180 x 260 mm |
Gewicht | 580 g |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Pneumologie |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
ISBN-10 | 1-62417-804-9 / 1624178049 |
ISBN-13 | 978-1-62417-804-7 / 9781624178047 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Aus der Praxis für die Praxis
Buch (2022)
Thieme (Verlag)
71,00 €
International Trauma Life Support (ITLS)
Buch | Softcover (2024)
Hogrefe AG (Verlag)
70,00 €